Skip to main content
. 2023 Oct 19;14:6618. doi: 10.1038/s41467-023-42190-w

Table 2.

Incidence of infection during household survey visits and symptomatic clinic visits, by Plasmodium species

Survey population Clinic subpopulation
At-risk pop. n Cumulative events (infections)a Crude risk (%) (95% CI) At-risk pop.b n Cumulative events (infections)a,c Crude risk (%) (95% CI)
P. malariae
     Baseline 1518 0 1002 0
     Month 6 1398 20 1.4 (0.8–2.1) 934 24 2.5 (1.5–3.5)
     Month 12 1230 67 4.9 (3.7–6.0) 910 48 5.0 (3.6–6.4)
     Month 18 744 86 7.0 (5.5–8.4) 890 68 7.1 (5.5–8.7)
     Month 24 -- -- -- 875 83 8.7 (6.9–10.4)
P. ovale spp.
     Baseline 1559 0 1001 0
     Month 6 1425 23 1.6 (1.0–2.3) 990 12 1.2 (0.5–1.9)
     Month 12 1279 49 3.4 (2.4–4.3) 972 30 3.0 (1.9–4.0)
     Month 18 769 55 4.1 (3.0–5.1) 951 51 5.1 (3.7–6.4)
     Month 24 -- -- -- 938 64 6.4 (4.9–7.9)
P. falciparum
     Baseline 1081 0 662 0
     Month 6 774 227 22.5 (19.9–25.0) 520 143 21.6 (18.4–24.6)
     Month 12 529 423 42.8 (39.6–45.8) 323 341 51.4 (47.5–55.1)
     Month 18 167 458 51.4 (47.6–55.0) 238 425 64.1 (60.3–67.6)
     Month 24 -- -- -- 211 452 68.2 (64.4–71.5)

CI confidence interval.

aCumulative first infections detected. Time to the first incident infection event.

bThe at-risk population for the clinic subpopulation comprises subjects who were PCR-negative for each species-specific infection at baseline and had at least one visit to study health clinics during the follow-up period.

cIncludes infections detected only at symptomatic clinic visits.